Inherited Retinal Disease

Juvenile X-linked Retinoschisis (XLRS)

A rare inherited retinal disease that affects the structure and function of the retina, particularly the macula, the area responsible for detailed central vision.

Understanding Juvenile X-linked Retinoschisis

Juvenile X-linked Retinoschisis (XLRS) is a rare inherited retinal disease that primarily affects males and usually becomes apparent during childhood. It is caused by changes in the RS1 gene, which affect the normal structure and function of the retina.

The condition is characterised by the splitting of retinal layers, known as retinoschisis. This often affects the macula, the central area of the retina responsible for detailed vision, and can lead to reduced visual acuity and difficulties with reading, recognising faces and other close-up tasks.

The severity and progression of XLRS vary between individuals. Some people experience relatively stable vision, while others develop greater visual impairment or complications such as retinal detachment or bleeding within the eye.

Advances in genetic diagnosis, retinal imaging and gene therapy research are improving understanding of XLRS and creating new opportunities for potential treatments. Retina International works with people affected by XLRS, patient organisations, researchers, clinicians and partners worldwide to advance research, strengthen patient involvement and improve outcomes for people living with inherited retinal diseases.

1 gene

Caused by changes in the RS1 gene, which provides instructions for the retinoschisin protein.

X-linked inheritance

Primarily affects males, while females are usually carriers because the RS1 gene is located on the X chromosome.

Childhood onset

Usually diagnosed during childhood

Symptoms

How Juvenile X-linked Retinoschisis can affect vision

Symptoms often appear in childhood, although the severity can vary. Common symptoms include:
Reduced central vision

Damage to the macula can affect the ability to see fine details clearly.

Difficulty reading

Children may experience challenges with:

  • Reading textbooks
  • Seeing classroom materials
  • Completing detailed tasks
Blurred vision

Reduced visual clarity is common.

Squinting or eye misalignment

Some children with XLRS may develop strabismus.

Nystagmus

Involuntary eye movements may occur.

Reduced depth perception

Changes in central vision may affect spatial judgement.

Complications

Some individuals may experience:

  • Retinal detachment
  • Vitreous haemorrhage (bleeding inside the eye)

These complications require urgent assessment by an eye specialist.

Diagnosis

Identifying Juvenile X-linked Retinoschisis

Diagnosis involves clinical examination, retinal imaging, functional testing, and genetic analysis. Assessment may include:
Eye examination

An ophthalmologist examines the retina and looks for characteristic changes.

Optical coherence tomography (OCT)

OCT is a key diagnostic tool in XLRS. It provides detailed images showing separation between retinal layers and helps monitor changes over time.

Fundus photography

Retinal photographs help document retinal appearance and progression.

Visual function testing

Assessment may include:

  • Visual acuity testing
  • Visual field testing
Electroretinography (ERG)

ERG measures electrical responses from retinal cells and can provide additional diagnostic information.

Genetic testing

Testing for changes in the RS1 gene can confirm diagnosis.

A genetic diagnosis can help:

  • Clarify inheritance
  • Support relatives who may require testing
  • Provide access to research opportunities
  • Improve understanding of disease progression
Treatment & Management

Supporting vision and maintaining independence

There is currently no cure for Juvenile X-linked Retinoschisis. Management focuses on monitoring vision, supporting independence, and treating complications when they occur.
Regular monitoring

Routine eye examinations help:

  • Monitor retinal changes
  • Track vision over time
  • Identify complications early
Low vision support

Support may include:

  • Magnification devices
  • Assistive technology
  • Digital accessibility tools
  • Vision rehabilitation
Educational support

Children with XLRS may benefit from:

  • Accessible learning materials
  • Classroom accommodations
  • Support from vision specialists
Managing complications

Treatment may be required for complications such as:

  • Retinal detachment
  • Vitreous haemorrhage
Emerging treatments

Research is exploring treatments that target the underlying cause of XLRS, including:

  • Gene replacement therapies
  • Gene-based treatments
  • Retinal protection strategies
Living With Juvenile X-linked Retinoschisis

Supporting independence and participation

Living with Juvenile X-linked Retinoschisis can involve adapting to reduced vision during important stages of childhood, education, and career development.

Support may include:

  • Early access to low vision services
  • Educational accommodations
  • Assistive technology
  • Career support
  • Peer networks
  • Patient organisations

Because XLRS often begins early in life, timely support can help children build confidence and develop strategies for learning and independence.

Families may also benefit from genetic counselling to understand inheritance patterns and future risks.

The experiences of people living with XLRS help shape research priorities and improve patient-centred care.

Support & resources

Information and community support

A diagnosis of Juvenile X-linked Retinoschisis can raise questions about inheritance, education, future vision, and treatment options. Resources may include:

Take the Next Step

Juvenile X-linked Retinoschisis highlights the importance of genetic understanding, early support, and continued innovation in inherited retinal disease research.

Through collaboration between patients, families, researchers, clinicians, and organisations worldwide, progress continues towards improved diagnosis, better support, and future treatments that may preserve vision.

Newsletter

Stay connected with Retina International

Sign up for the latest research, advocacy news and events.

Retina International